Anheuser-Busch InBev Falls Short of Q3 Earnings Expectations

1 Mins read


Decline in Volumes

During the third quarter, Anheuser-Busch InBev reported a 3.4% decrease in overall volumes on an organic basis, missing market expectations of a 2.7% fall. Specifically, North America witnessed a significant decline in volumes, with a 17.1% drop compared to the previous quarter’s 14.5% decrease.

The decline in North American volumes can be attributed to a boycott that was sparked by a post made by Dylan Mulvaney, a transgender social-media star, on her Instagram account. Mulvaney shared an image of a personalized can of Bud Light gifted by the brewer, which led to negative publicity and subsequent sales drops for Bud Light and other brands.

Financial Performance

While earnings for the third quarter rose to $1.47 billion from the previous year’s $1.43 billion, it fell short of a FactSet consensus estimate of $1.85 billion. Similarly, revenue increased from $15.09 billion to $15.57 billion, driven by pricing actions, premiumization strategies, and other revenue-management moves. Despite the growth in revenue, it fell slightly short of the market consensus of $15.72 billion.

On an organic basis, revenue demonstrated strong growth, reaching 5.0%, exceeding the company’s own provided market consensus rise of 4.7%. Moreover, normalized earnings before interest, tax, depreciation, and amortization saw a slight increase to $5.43 billion from $5.31 billion.

Future Outlook

Anheuser-Busch InBev maintains its confidence in achieving its 2023 EBITDA growth target within the range of 4% to 8%, in line with its medium-term outlook. Furthermore, the company expects revenue to grow ahead of EBITDA, driven by a healthy combination of volume and price.


Despite the decline in volumes and falling short of market expectations, Anheuser-Busch InBev remains optimistic about its future prospects. The company will continue to employ strategies such as premiumization and revenue-management moves to drive growth. By leveraging a combination of volume and price, Anheuser-Busch InBev aims to achieve its long-term goals.

Related posts

GitLab Stock Surges on First Ever Adjusted Operating Profit

1 Mins read
GitLab’s stock experienced a significant surge on Tuesday following the announcement of its first ever adjusted operating profit. Despite this positive development,…

Virgin Galactic Faces Stock Decline Amid Founder's Money Decision

2 Mins read
Virgin Galactic stock experienced a sharp decline in early trading on Monday due to founder Richard Branson’s announcement that he won’t be…

EyePoint Pharmaceuticals Announces Positive Results in Phase 2 Trial for Macular Degeneration Treatment

1 Mins read
EyePoint Pharmaceuticals, a Massachusetts-based company, revealed exciting news on Monday regarding the second-phase trial of its investigational treatment for macular degeneration. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

77 − = 74